4:01 PM ET
8-K
Business Update
Acumen Pharmaceuticals Business Update
Acumen Pharmaceuticals is implementing a major restructuring plan that includes reducing its workforce by approximately 90% (52 employees) following the decision to cease development of its lead candidate, sabirnetug. The company estimates it will incur $7.75 million in severance-related charges and has also fully repaid its $23.3 million outstanding debt to K2 HealthVentures to conserve cash while evaluating strategic options.